Checkmate Pharmaceuticals, Inc. (CMPI)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Alan Bash
Employees:
30
245 MAIN STREET, 2ND FLOOR, CAMBRIDGE, MA, 02142
978-503-2124
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Are you looking for this stock instead?
Checkmate Pharmaceuticals, Inc. develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|